Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer

Cancer Genetics and Cytogenetics

Volumn 191, Issue 1, 2009, Pages 38-42

  Yamamoto, Yoshiaki ^a   Eguchi, Satoshi ^a   Junpei, Akao ^a   Nagao, Kazuhiro ^a   Sakano, Shigeru ^a   Furuya, Tomoko ^a   Oga, Atsunori ^a   Kawauchi, Shigeto ^a   Sasaki, Kohsuke ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; GAMMA TUBULIN; GAMMA TUBULIN ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOME; BLADDER CANCER; CANCER GROWTH; CELL ASSAY; CELL COUNT; CENTROSOME; CHROMOSOME NUMBER; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

CELL LINE, TUMOR; CENTROSOME; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; GENE DOSAGE; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 64649106997     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.01.012     Document Type: Article

References (19)

1. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
2. Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230 (2005) 6-19
3. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., Boeneman K., Liu W., Whitehead C.M., Reynolds C., and Salisbury J.L. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 99 (2002) 1978-1983
4. Pihan G.A., Wallace J., Zhou Y., and Doxsey S.J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63 (2003) 1398-1404
5. Akao J., Matsuyama H., Yamamoto Y., Sasaki K., and Naito K. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors. Clin Cancer Res 12 (2006) 7004-7008
6. Kawamura K., Moriyama M., Shiba N., Ozaki M., Tanaka T., Nojima T., Fujikawa-Yamamoto K., Ikeda R., and Suzuki K. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 43 (2003) 505-515
7. Yamamoto Y., Matsuyama H., Furuya T., Oga A., Yoshihiro S., Okuda M., Kawauchi S., Sasaki K., and Naito K. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Clin Cancer Res 10 (2004) 6449-6455
8. Yamamoto Y., Matsuyama H., Kawauchi S., Furuya T., Liu X.P., Ikemoto K., Oga A., Naito K., and Sasaki K. Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res 12 (2006) 2752-2758
9. Dodson H., Bourke E., Jeffers L.J., Vagnarelli P., Sonoda E., Takeda S., Earnshaw W.C., Merdes A., and Morrison C. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. Embo J 23 (2004) 3864-3873 (Epub 2004 Sep 09)
10. Borel F., Lohez O.D., Lacroix F.B., and Margolis R.L. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc Natl Acad Sci USA 99 (2002) 9819-9824
11. Meraldi P., Honda R., and Nigg E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. Embo J 21 (2002) 483-492
12. Tarapore P., and Fukasawa K. Loss of p53 and centrosome hyperamplification. Oncogene 21 (2002) 6234-6240
13. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., and Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103 (2000) 127-140
14. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., and Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20 (1998) 189-193
15. Lentini L., Amato A., Schillaci T., and Di Leonardo A. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype. BMC Cancer 7 (2007) 212
16. Fukasawa K. p53, cyclin-dependent kinase and abnormal amplification of centrosomes. Biochim Biophys Acta 1786 (2008) 15-23
17. Matsuyama H., Bergerheim U.S., Nilsson I., Pan Y., Skoog L., Tribukait B., and Ekman P. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77 (1994) 118-124
18. Tsukamoto M., Matsuyama H., Oba K., Yoshihiro S., Takahashi M., and Naito K. Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence. Cancer Genet Cytogenet 134 (2002) 41-45
19. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B.L., Murphree A.L., Strong L.C., and White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305 (1983) 779-784